Formerly | Southwest Synthetic Pharmaceuticals | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Company type | public | ||||||||||||||
SZSE: 000788 | |||||||||||||||
Industry | pharmaceutical | ||||||||||||||
Headquarters | Chongqing , China | ||||||||||||||
Revenue | CN¥2.011 billion (2015) | ||||||||||||||
(CN¥ million) 45 (2015) | |||||||||||||||
CN¥ 25 million (2015) | |||||||||||||||
Total assets | CN¥3.124 billion (2015) | ||||||||||||||
Total equity | CN¥1.133 billion (2015) | ||||||||||||||
Owner |
| ||||||||||||||
Parent |
| ||||||||||||||
Website | pku-hc.com | ||||||||||||||
Footnotes /references in consolidated financial statement |
PKU Healthcare Corp., Ltd. | |||
---|---|---|---|
Simplified Chinese | 北大医药股份有限公司 | ||
| |||
PKU Healthcare | |||
Simplified Chinese | 北大医药 | ||
|
PKU Healthcare Co.,Ltd. formerly known as PKU International Healthcare Group Southwest Pharmaceutical Co.,Ltd.,is a Chinese pharmaceutical company. The major shareholder was PKU Healthcare Group,a subsidiary of PKU Founder Group. PKU Founder Group itself is a subsidiary of Peking University,in turn making the listed company a state-owned enterprise by broader definition.
PKU International Healthcare Group Southwest Pharmaceutical Co.,Ltd. (Chinese :北大国际医院集团西南合成制药股份有限公司;lit.'Peking University International Hospital Group Southwest Synthetic Pharmaceutical','Company Limited by Shares') known also as Southwest Synthetic Pharmaceuticals (Chinese :西南合成),is an indirect subsidiary of Peking University since 2003. In 2013 the company was renamed into PKU Healthcare Corp.,Ltd. (Chinese :北大医药股份有限公司). [1]
Southwest Synthetic Pharmaceutical Co.,Ltd. (Chinese :西南合成制药股份有限公司) was incorporated on 18 May 1993 as a subsidiary of Southwest Synthetic Pharmaceutical Factory (Chinese :西南合成制药总厂),which was owned by Chongqing Municipal People's Government . The factory itself was founded in 1965.
Due to financial difficulties,1.26% shares of the listed company was acquired by Sichuan No.2 Electric Power Construction in 2001 from the parent entity (Southwest Synthetic Pharmaceutical Factory). [2]
In 2002 47.31% shares of the listed company was entrusted to a private company (Chinese :南方同正投资) by the parent (Southwest Synthetic Pharmaceutical Factory). [3] In June 2003,China Huarong Asset Management,the state-owned bad bank,made a public offer to sell the credit of themselves to the parent entity (Southwest Synthetic Pharmaceutical Factory); [4] On 4 September the parent entity was re-incorporated as Chongqing Southwest Synthetic Pharmaceutical Co.,Ltd. (Chinese :重庆西南合成制药有限公司), [nb 1] with part of the debt was converted into share capital,making state-owned China Development Bank owned 39.80% share capital as second largest shareholder. [5] On 1 July of the same year,the management of the intermediate parent company (Southwest Synthetic Pharmaceutical Group) was also entrusted to state-owned PKU Founder Group,the aforementioned trust contract regarding the shares of the listed company,that was signed with aforementioned private company,was also canceled on the same day;On 29 September,an agreement was formed between Founder Group,China Development Bank and the ultimate owner (Chinese :重庆化医控股集团),which Founder Group would acquired a majority stake (about 70%) in the intermediate parent company (Southwest Synthetic Pharmaceutical Group) by subscription of new share capital of CN¥300 million,as well as withdrew of China Development Bank by selling the 39.80% share capital to the original major shareholder (Chinese :重庆化医控股集团),making Founder Group was the indirect major shareholder of the listed company for 47.31% share. [6]
Since acquired by PKU Founder Group,Southwest Synthetic Pharmaceutical received assets from the parent company and renamed to PKU Healthcare in 2013.
As at 31 December 2015,PKU Healthcare Group (Chinese :北大医疗产业集团) owned 40.38% shares of PKU Healthcare directly and indirectly (via Southwest Pharmaceutical Group Chinese :西南合成医药集团) as the largest shareholder;PKU Founder Group was the parent company of PKU Healthcare Group for 85.60%,with the rest were owned by Peking University ;Peking University's wholly owned subsidiary:Peking University Asset Management owned 70% stake of PKU Founder Group;as Peking University was supervised by the Ministry of Education,PKU Healthcare was considered a state-owned enterprise in a border definition;Peking University Asset Management also owned an additional 0.36% via another subsidiary (40.74% in total). [7]
The second largest shareholder was China Securities Finance for 1.94% shares.
PKU Healthcare Group owned 51.95% shares at 31 December 2012. [8] During 2013 6.71% shares were sold to Beijing Zenith Holdings (Chinese :北京政泉控股) a private company that was linked to Guo Wengui for CN¥368 million (CN¥9.20 per share) [9] and an additional 5.03% shares were sold to Peking University Education Foundation. [10] [11] However,it was later found that the private company did not pay PKU Healthcare Group due to its financial difficulty. Instead,the company signed an agreement with PKU Resources Group Holdings,sister company of PKU Healthcare Group to hold the shares of the listed company as a proxy of PKU Resources Group Holdings. [12] All 3 companies were fined by China Securities Regulatory Commission in 2016. [13]
Zenith Holdings also sold the shares in 2014 (1.73% for CN¥17.98 each [14] and an additional 4.44% [15] for undisclosed price) and in 2015;at the same time PKU Healthcare Group announced that the company would bought back not more than 2% shares in November 2014 from public market. [16] In July 2015 0.18% shares were bought for CN¥18.28 each. [17] In October PKU Healthcare announced that the share buy back program was completed. [18]
Founder Group (方正集团) is a major Chinese technology conglomerate that deals with information technology, pharmaceuticals, real estate, finance, and commodities trading. It is divided into five major industry groups, each covering a separate industry: PKU Founder IT Group (IT), PKU Healthcare Group, PKU Resource Group, Founder Financial (finance), and Founder Commodities. The group has been coping with bankruptcy since 2020, when the Beijing No.1 Intermediate People's Court announced the recognized leader during the restructuring.
China International Marine Containers (Group) Co., Ltd is a Chinese company principally engaged in the manufacture and sale of transportation equipment, such as containers, road transport vehicles and airport ground-handling equipment.
Shenzhen Kejian Group Co., Ltd., better known as Kejian, was a Chinese telecommunications company.
Wanhua Chemical Group Co., Ltd. known as Wanhua Chemical and formerly Yantai Wanhua Polyurethane or Yantai Wanhua Polyurethanes or Yantai Wanhua, is a Chinese listed company in chemical industry.
Wanhua Industrial Group Co., Ltd. is a Chinese holding company. It was the parent company of Wanhua Chemical Group and BorsodChem until 2018. Yantai Municipal People's Government, via Yantai Guofeng, still owned 39.497% stake of the company as of 2017. The government also sold 25% stake of the company to a consortium of Pemex and Deutsche Bank in 2007.
Oceanwide Holdings Co., Ltd. is a Chinese publicly traded conglomerate. It was a subsidiary of Tohigh Holding, via intermediate holding companies Oceanwide Group and China Oceanwide Holdings Group.
Suning Appliance Group Co., Ltd. is a Chinese holding company that is the third largest shareholder of Suning Appliance, after Zhang Jindong and Alibaba Group.
Baoshan Iron & Steel Co., Ltd., also known as Baoshan Iron & Steel and Baosteel, is a maker of steel based in Shanghai, China, and a subsidiary of state-owned China Baowu Steel Group. It is listed on the Shanghai Stock Exchange.
Shanghai Meishan Iron and Steel Co., Ltd., known as Meishan Iron and Steel, or Meisteel or Meigang is a second-tier subsidiary of Baowu and a first-tier subsidiary of listed company Baoshan Iron and Steel Co., Ltd. (Baosteel). The company was based in Nanjing.
Baosteel Group Guangdong Shaoguan Iron and Steel Co., Ltd. known as Shaoguan Iron and Steel or SGIS or Shaogang or Shaosteel is a Chinese steel maker.
Taiyuan Coal Gasification (Group) Co., Ltd. is a Chinese state-owned coal mining conglomerate based in Taiyuan, Shanxi. The company was owned by State-owned Assets Supervision and Administration Commission (SASAC) of Shanxi Provincial People's Government. However, Shanxi SASAC granted fellow state-owned enterprise Jincheng Anthracite Mining Group (JAMG) to manage their stake since 2011.
Jiangsu Shagang Group Huaigang Special Steel Co., Ltd. is a Chinese steel manufacturer based in Huai'an, Jiangsu Province. It was a subsidiary of privately held company Shagang Group via its publicly traded subsidiary Shagang Company for 63.79% stake, from 2010 to 2015. As at 31 December 2013, Huaigang accounted for 99.9% revenue and 97% assets of Shagang Company. However, as at 31 December 2015, Shagang Group owned just 19.88% stake in Shagang Company; in turn Shagang Company owned 63.79% stake of Huaigang. Shagang Group sold 55.12% stake of Shagang Company in 2015, for about CN¥4.6 billion.
Peking University Resources (Holdings) Co., Ltd. known also as PKU Resources is a Chinese listed company. The company was incorporated in Bermuda and listed in the Hong Kong Stock Exchange. The company is an indirect non-wholly-owned subsidiary of Peking University, which in turn under the administration of the Ministry of Education. The company is broadly considered a state-owned enterprise of China. For the same reason, PKU Resources is a red chip company.
Sinobioway Group Co., Ltd. was one of the university-owned enterprises of Peking University. The company currently majority (60%) owned by a Peking University professor and other employee of Peking University. The pinyin of the Chinese short name was Wèimíng Jítuán, literally Anonymous Group. However, Sinobioway was not related to other Weiming Group, such as Weiming (Fujian) Investment Group.
Hainan HNA Infrastructure Investment Group Co., Ltd. formerly Hainan Island Construction Co., Ltd. is a Chinese listed company based in Haikou. in mid-2016 the company acquired HNA Infrastructure Group (Chinese: 海航基础产业集团) in a reverse IPO from intermediate parent company HNA Infrastructure Holding Group (Chinese: 海航基础控股集团), which HNA Infrastructure Group is the parent company of HNA Real Estate and HNA Airport Group (Chinese: 海航机场集团, in turn HNA Airport Group is the parent company of HNA Airport Holdings (Group) (Chinese: 海航机场控股(集团)) and HNA Airport Holdings is the parent company of Sanya Phoenix International Airport Co., Ltd.); HNA Airport Group is the largest shareholder of Haikou Meilan International Airport (19.58% as at October 2016), which in turn the largest shareholder of Hong Kong listed company HNA Infrastructure. In December 2016 a proposed capital increase of the HK-listed company was announced. HNA Infrastructure Investment Group would purchase a minority share directly. Haikou Meilan International Airport was the second-largest shareholder of Hainan Airlines; Hainan Airlines, however, also owned a minority stake in Haikou Meilan International Airport.
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue.
Jiangsu Sainty Corporation Limited is a Chinese listed company based in Nanjing, Jiangsu Province. The company exported clothes to overseas.
China Hi-Tech Group Co., Ltd., is a Chinese company engaged in the provision of educational technology. It was established by a number of Chinese universities and the Chinese Ministry of Education. It is closely held by the Chinese government through Founder Group.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.